参考文献

［1］ ZENI L, NORDEN AGW, CANCARINI G, et al. A more tubulocentric view of diabetic kidney disease [J]. J Nephrol, 2017, 30 (6): 701-717.

［2］ POURGHASEM M, SHAFI H, BABAZADEH Z. Histological changes of kidney in diabetic nephropathy [J]. Caspian J Intern Med, 2015, 6 (3): 120-127.

［3］ 李静, 梁田田, 王文健. 糖尿病肾病的早期诊断 [J]. 中华肾脏病杂志, 2017, 33 (6): 470-475.

［4］ AN Y, XU F, LE W, et al. Renal histologic changes and the outcome in patients with diabetic nephropathy [J]. Nephrol Dial Transplant, 2015, 30 (2): 257-266.

［5］ 刘志红, 曾彩虹, 梁丹丹. 肾活检病理诊断报告模式专家共识 [J]. 中国实用内科杂志,2017, 37 (9): 810-816.

［6］ SETHI S, HAAS M, MARKOWITZ G S, et al. Mayo Clinic/Renal Pathology Society consensus report on pathologic classification, diagnosis, and reporting of GN [J]. J Am Soc Nephrol, 2016, 27 (5): 1278-1287.

［7］ ZHU X, XIONG X, YUAN S, et al. Validation of the interstitial fibrosis and tubular atrophy on the new pathological classification in patients with diabetic nephropathy: A single-center study in China [J]. J Diabetes Complications, 2016, 30 (3): 537-541.

［8］ QI C, MAO X, ZHANG Z, et al. Classification and differential diagnosis of diabetic nephropathy [J]. J Diabetes Res, 2017, 2017: 8637138.

［9］ NASR S H, VRANA J A, DASARI S, et al. DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis [J]. Kidney Int Rep, 2018, 3 (1): 56-64.

［10］ HAMRAHIAN M, MOLLAEE M, ANAND M, et al. Impaired glucose metabolism-A potential risk factor for idiopathic nodular glomerulosclerosis: A single center study [J]. Med Hypotheses, 2018, 121: 95-98.

［11］ NAKAMURA N, TAGUCHI K, MIYAZONO Y, et al. AGEs-RAGE overexpression in a patient with smoking-related idiopathic nodular glomerulosclerosis [J]. CEN Case Rep, 2018, 7 (1): 48-54.

［12］ NASR S H, FIDLER M E, SAID S M. Paraffin Immunofluorescence: A valuable ancillary technique in renal pathology [J]. Kidney Int Rep, 2018, 3 (6): 1260-1266.

［13］ HALFON M, ROTMAN S, EGLI M, et al. Continuous subcutaneous insulin pump treatment associated with absence of recurrent kidney allograft diabetic nephropathy [J]. Acta Diabetol, 2015, 52 (6):1175-1177.

［14］ COHEN J B, EDDINGER K C, LOCKE J E, et al. Survival Benefit of transplantation with a deceased diabetic donor kidney compared with remaining on the waitlist [J]. Clin J Am Soc Nephrol, 2017, 12 (6):974-982.

［15］ TRUONG L D, GABER L W, KHAN F. Donor-related diabetic nephropathy: a comprehensive clinicopathological study [J]. Hum Pathol, 2018, 10: 32.

［16］ HARADA S, USHIGOME H, NISHIMURA A, et al. Histological reversibility of diabetic nephropathy after kidney transplantation from diabetic donor to non-diabetic recipient [J]. Nephrology (Carlton), 2015,20 (Suppl 2): 40-44.